Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
59.00    2.50 (4.42%)
Bid:
58.00
Ask:
60.00
Spread: 2.00 (3.448%)
Market Cap: £55.91m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Trading Statement

5 May 2023 07:00

RNS Number : 4993Y
TPXimpact Holdings PLC
05 May 2023
 

5 May 2023

TPXimpact Holdings PLC

("TPX", "TPXimpact", or the "Company")

Trading Update

Current trading at the higher end of previous forecasts and updated guidance for FY24 & FY25

 

TPXimpact Holdings PLC (AIM: TPX), the technology-enabled services company focused on digital transformation, is pleased to provide an update on its Q4 and full year trading for the year ended 31 March 2023 and to provide guidance for the full years ending 31 March 2024 and 2025.

Q4 and Full Year Trading

Trading for the fourth quarter of the year was at the higher end of previous guidance.

As a result, and based on the Group's unaudited management accounts for the year, the Board expects to report revenue of c.£83 million with an Adjusted EBITDA margin of approximately 3%. Net debt (excluding lease liabilities) was below £18 million at 31 March 2023.

New business generation was strong during the fourth quarter, totalling £36 million, and that momentum has continued into the new financial year. April 2023 marked a record for the Group with new business wins exceeding £80 million, highlighting the opportunity available for TPX as it secures larger contracts while optimised for efficiency under one brand. This was primarily due to the two major new contracts announced on 28 April with HMLR (His Majesty's Land Registry) for up to £49 million over four years and the Department for Education for £27.5 million over two years, both commencing May 2023. These wins provide a solid foundation for the current financial year and beyond.

The Board expects to release the Group's preliminary, unaudited results for the year ended 31 March 2023 in late June 2023 and will provide more detail on the FY23 outturn at that time.

Outlook

The Group has completed its budgeting process for the year ending 31 March 2024 (FY24). As a result of strong new business performance, the Board is raising its guidance on organic revenue growth to 15-20% for FY24 (from 10-15% previously) and is targeting an Adjusted EBITDA margin of 5-6%, which also reflects continued investment in our people and systems. Management expect margin improvement to be weighted to the second half of the year.

Committed (or backlog) revenues for FY24 are currently around £80 million, which compares with £41 million at the same time last year.

With respect to FY25, management are targeting organic revenue growth of 10-15% and a further improvement in Adjusted EBITDA margin of 2-3% on top of that targeted for FY24.

Debt covenants

Further to the trading update announced on 31 March 2023, and the waiver of the Group's debt covenant tests at that date, management continue to engage positively with the Group's bankers in relation to their review of the Group's short and medium term cash flow forecasts. These discussions are ongoing and the Board will provide an update in due course.

- Ends -

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for this announcement is Steve Winters, Group CFO.

Enquiries:

TPXimpact Holdings PLC

Bjorn Conway, Group CEO

Steve Winters, Group CFO

 

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

Alex Price

Fred Walsh

Ben Burnett

 

Via Alma PR

 

 

 

+44 (0) 207 710 7600

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

Russell Cook

 +44 (0) 203 903 7715

Alma PR

(Financial PR)

Josh Royston

Kieran Breheny

Matthew Young

+44 (0) 203 405 0209

tpx@almapr.co.uk

 

 

 

About TPXimpact

TPXimpact exists to transform the organisations, services and systems that underpin society and that drive business success. It applies strategic and creative thinking, technology, innovative design and user-centred approaches to bring about numerous improvements which together multiply the impact of change.

The Company works closely with its clients in agile, multidisciplinary teams that span organisational design, technology, and digital experiences. It shares a deep understanding of people and behaviours and a philosophy of putting people and communities at the heart of every transformation.

The business is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.65% of its client base representing the public sector and c.35% representing the commercial sector.

More information is available at www.tpximpact.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBCGDUUGGDGXS
Date   Source Headline
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDirector/PDMR Shareholding
1st Feb 202311:05 amRNSSecond Price Monitoring Extn
1st Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSBlocklisting Return
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSQ3 Trading Update
17th Jan 20237:00 amRNSDividend Payment Update
11th Jan 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
3rd Jan 20231:43 pmRNSTotal Voting Rights
12th Dec 202211:20 amRNSIssue of Shares, Transfer of Shares from EBT & TVR
9th Dec 20227:00 amRNSHolding(s) in Company
5th Dec 20225:14 pmRNSDirector/PDMR Shareholdings and TVR
30th Nov 20227:00 amRNSInterim Results
11th Nov 20227:00 amRNSIssue of Shares
1st Nov 20227:00 amRNSTotal Voting Rights
21st Oct 20227:00 amRNSConfirmation of board appointments
13th Oct 20227:00 amRNSIssue of Shares, PDMR dealings and TVR
10th Oct 20227:00 amRNSDirector/PDMR Shareholdings
7th Oct 20222:05 pmRNSSecond Price Monitoring Extn
7th Oct 20222:00 pmRNSPrice Monitoring Extension
7th Oct 20227:00 amRNSDirector/PDMR Shareholdings
6th Oct 20227:00 amRNSDirector/PDMR Shareholdings
5th Oct 20227:00 amRNSDirector/PDMR Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.